- Ongoing, recruitingTherapeutic use (Phase IV)
Maternal determinants of infant immunity to pertussis (MADI-02)
This study, called MADI-02, is looking at how well mums pass on protection against whooping cough to their babies. Researchers are testing different whooping cough vaccines to see which ones create the best immune response in mums.
For: Whooping coughBelgium - AuthorisedTherapeutic use (Phase IV)
The optimal timing of vaccination in pregnancy: a multi-dimensional mechanistic approach to measure immune responses in pregnant women (MATIMMUNE)
This study looks at how well the whooping cough vaccine (Tdap) works in pregnant women. Researchers want to find the best time during pregnancy to have the vaccine to protect both mum and baby. They will check the mum's immune response and how many protective antibodies pass to the baby.
For: PregnantBelgium